Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly
Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly Reuters
Yahoo News Novo Nordisk's CEO says only the Covid vaccine beat this launch | Sozzi Unleashed
Mike Doustdar took over at Novo Nordisk in August 2025, and he tells Brian Sozzi the obesity pill has had the biggest launch of any product he can think of apart from the Covid vaccine. It is on sale in eight...
Lean: Center VideoFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Apollo Global Management


















